Search - tctmd.com

Displaying 61 - 80 of 97

Sort: Relevancy | Date

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Caitlin E. Cox

October 06, 2023

News Daily News

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

Shelley Wood

September 28, 2023

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

Todd Neale

August 08, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

L.A. McKeown

March 31, 2023

News Daily News

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

L.A. McKeown

March 24, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Daily News

Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets

L.A. McKeown

January 18, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

Yael L. Maxwell

August 03, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

Advertisement

FDA Grants Tirzepatide a New Indication for Obesity Management

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content